Jürgen Braun

55.4k total citations · 14 hit papers
583 papers, 31.4k citations indexed

About

Jürgen Braun is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Jürgen Braun has authored 583 papers receiving a total of 31.4k indexed citations (citations by other indexed papers that have themselves been cited), including 529 papers in Rheumatology, 240 papers in Immunology and 139 papers in Hematology. Recurrent topics in Jürgen Braun's work include Spondyloarthritis Studies and Treatments (474 papers), Rheumatoid Arthritis Research and Therapies (358 papers) and Psoriasis: Treatment and Pathogenesis (207 papers). Jürgen Braun is often cited by papers focused on Spondyloarthritis Studies and Treatments (474 papers), Rheumatoid Arthritis Research and Therapies (358 papers) and Psoriasis: Treatment and Pathogenesis (207 papers). Jürgen Braun collaborates with scholars based in Germany, United States and Netherlands. Jürgen Braun's co-authors include Joachim Sieper, Désirée van der Heijde, Xenofon Baraliakos, Martín Rudwaleit, Joachim Listing, J. Brandt, Hildrun Haibel, Maxime Dougados, Kay‐Geert Hermann and John C. Davis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Jürgen Braun

549 papers receiving 30.3k citations

Hit Papers

Ankylosing spondylitis 1995 2026 2005 2015 2007 2009 2002 2015 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ankylosing spondylitis
    2007 1.4k citations Jürgen Braun, Joachim Sieper profile →
  2. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
    2009 1.2k citations Joachim Sieper, Martín Rudwaleit et al. Annals of the Rheumatic Diseases profile →
  3. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
    2002 953 citations Jürgen Braun, Joachim Listing et al. profile →
  4. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
    2015 732 citations Joachim Sieper, Jürgen Braun et al. profile →
  5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
    2006 660 citations Désirée van der Heijde, Joachim Sieper et al. profile →
  6. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis
    2003 655 citations Désirée van der Heijde, Jürgen Braun et al. profile →
  7. Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
    2005 651 citations Désirée van der Heijde, Joachim Sieper et al. profile →
  8. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group
    2009 649 citations Martín Rudwaleit, Kay‐Geert Hermann et al. Annals of the Rheumatic Diseases profile →
  9. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
    2003 583 citations John C. Davis, Désirée van der Heijde et al. profile →
  10. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
    2010 549 citations Robert Landewé, Jürgen Braun et al. Annals of the Rheumatic Diseases profile →
  11. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
    1995 532 citations Jürgen Braun et al. profile →
  12. The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort
    2009 512 citations Martín Rudwaleit, Hildrun Haibel et al. profile →
  13. A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
    2013 448 citations Jürgen Braun et al. Annals of the Rheumatic Diseases profile →
  14. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial
    2008 444 citations Robert D. Inman, John C. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Braun Germany 90 27.3k 15.0k 9.0k 4.1k 2.2k 583 31.4k
Joachim Sieper Germany 101 32.8k 1.2× 18.7k 1.2× 11.0k 1.2× 4.7k 1.1× 3.1k 1.4× 551 37.6k
Maxime Dougados France 74 19.5k 0.7× 9.4k 0.6× 6.9k 0.8× 2.2k 0.5× 1.5k 0.7× 546 23.9k
Robert Landewé Netherlands 83 20.5k 0.8× 8.8k 0.6× 6.7k 0.7× 2.6k 0.6× 2.4k 1.1× 532 25.0k
Walter P. Maksymowych Canada 70 14.4k 0.5× 6.9k 0.5× 4.5k 0.5× 4.2k 1.0× 1.8k 0.8× 520 18.0k
Martín Rudwaleit Germany 71 17.1k 0.6× 9.0k 0.6× 5.2k 0.6× 3.0k 0.7× 1.4k 0.6× 310 18.8k
Maxime Dougados France 83 18.9k 0.7× 6.4k 0.4× 5.4k 0.6× 2.4k 0.6× 1.6k 0.7× 395 24.8k
Mikkel Østergaard Denmark 70 15.5k 0.6× 3.7k 0.2× 4.5k 0.5× 3.5k 0.9× 846 0.4× 560 18.2k
John D. Reveille United States 79 14.3k 0.5× 9.0k 0.6× 3.1k 0.3× 563 0.1× 2.1k 0.9× 384 21.3k
Michelle Petri United States 99 25.7k 0.9× 16.7k 1.1× 3.2k 0.4× 381 0.1× 2.6k 1.2× 534 33.5k
Philip Helliwell United Kingdom 58 11.8k 0.4× 8.7k 0.6× 6.2k 0.7× 1.1k 0.3× 495 0.2× 394 15.3k

Countries citing papers authored by Jürgen Braun

Since Specialization
Citations

This map shows the geographic impact of Jürgen Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Braun more than expected).

Fields of papers citing papers by Jürgen Braun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Braun. The network helps show where Jürgen Braun may publish in the future.

Co-authorship network of co-authors of Jürgen Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Braun. A scholar is included among the top collaborators of Jürgen Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Braun. Jürgen Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baraliakos, Xenofon, Mikhail Protopopov, Valeria Ríos Rodríguez, et al.. (2025). Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time? Comparison of blinded versus unblinded mSASSS scoring. Annals of the Rheumatic Diseases. 84(8). 1335–1341.
2.
3.
Hooge, Manouk de, Alexandre Sepriano, Xenofon Baraliakos, et al.. (2024). Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD Open. 10(2). e004199–e004199. 1 indexed citations
4.
Ziegeler, Katharina, Fabian Proft, Mikhail Protopopov, et al.. (2024). Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD Open. 10(2). e004044–e004044. 6 indexed citations
5.
Braun, Jürgen, Elisabeth Märker‐Hermann, Martín Rudwaleit, & Joachim Sieper. (2024). HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis. Annals of the Rheumatic Diseases. 83(11). 1406–1408. 2 indexed citations
6.
Braun, Jürgen & Denis Poddubnyy. (2024). Diagnostik und Klassifikation der axialen Spondyloarthritis (axSpA) – der aktuelle Stand. DMW - Deutsche Medizinische Wochenschrift. 149(9). 513–520.
7.
Kiefer, David, Jürgen Braun, Uta Kiltz, et al.. (2024). Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD Open. 10(1). e003733–e003733. 3 indexed citations
8.
Heijde, Désirée van der, Xenofon Baraliakos, Jürgen Braun, et al.. (2023). Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD Open. 9(1). e002836–e002836. 1 indexed citations
9.
Albrecht, Katinka, K. Thiele, Martin Aringer, et al.. (2023). POS1090 IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRES. Annals of the Rheumatic Diseases. 82. 868–869. 1 indexed citations
10.
Sepriano, Alexandre, Xenofon Baraliakos, Rosaline van den Berg, et al.. (2022). Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. Lara D. Veeken. 61(12). 4722–4730. 11 indexed citations
11.
Abrar, Daniel B., Christoph Schleich, Miriam Frenken, et al.. (2021). Annual Meeting Abstracts of the German Society of Skeletal Radiology (DGMSR) 2021, April 23 – 24, Berlin/ Germany. Skeletal Radiology. 50(5). 1057–1063.
12.
13.
14.
Braun, Jürgen, et al.. (2019). Identifikation von Patienten mit axialer Spondyloarthritis in der Primärversorgung (AWARE-Studie). Zeitschrift für Rheumatologie. 78(6). 568–576. 4 indexed citations
15.
Maksymowych, Walter P., Maxime Dougados, Désirée van der Heijde, et al.. (2015). Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Annals of the Rheumatic Diseases. 75(7). 1328–1335. 80 indexed citations
16.
Poddubnyy, Denis, I. Z. Gaydukova, Kay‐Geert Hermann, et al.. (2013). Magnetic Resonance Imaging Compared to Conventional Radiographs for Detection of Chronic Structural Changes in Sacroiliac Joints in Axial Spondyloarthritis. The Journal of Rheumatology. 40(9). 1557–1565. 52 indexed citations
17.
Braun, Jürgen, et al.. (2011). Weiterbildung – eine zentrale Aufgabe für DGRh und Rheumaakademie. Zeitschrift für Rheumatologie. 70(8). 701–711. 8 indexed citations
18.
Braun, Jürgen, Xenofon Baraliakos, Joachim Listing, et al.. (2007). Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents. Arthritis Care & Research. 57(4). 639–647. 145 indexed citations
19.
Braun, Jürgen, Joachim Sieper, Maxime Bréban, et al.. (2002). Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience. Annals of the Rheumatic Diseases. 61. iii51–iii60. 46 indexed citations
20.
Zink, A., Jürgen Braun, Joachim Listing, & J. Wollenhaupt. (2000). Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.. PubMed. 27(3). 613–22. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Sieper Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Robert Landewé Breakdown of academic impact, for papers by Walter P. Maksymowych Breakdown of academic impact, for papers by Martín Rudwaleit Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Mikkel Østergaard Breakdown of academic impact, for papers by John D. Reveille Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Philip Helliwell
Rankless by CCL
2026